CrATP interferes in the promastigote-macrophage interaction in Leishmania amazonensis infection

V Ennes-Vidal1, R O S Castro, C Britto

  • 1Laboratório de Biologia Molecular e Doenças Endêmicas, Instituto Oswaldo Cruz/FIOCRUZ, Rio de Janeiro, RJ, Brazil.

Parasitology
|June 18, 2011
PubMed

Insights

CrATP partially inhibits ecto-ATPase activity and drastically inhibits Leishmania amazonensis growth. This compound significantly reduces parasite adhesion and endocytosis by macrophages, highlighting ecto-nucleotidase

Area of Science:

  • Parasitology
  • Biochemistry
  • Molecular Biology

Background:

  • Ecto-Nucleoside-Triphosphate-Diphosphohydrolases (Ecto-NTPDases) are linked to virulence in trypanosomatids.
  • Understanding Ecto-NTPDases in Leishmania amazonensis is crucial for developing anti-parasitic strategies.

Purpose of the Study:

  • To characterize the inhibition of ecto-ATPase activity and promastigote growth of Leishmania amazonensis by CrATP.
  • To investigate the role of ecto-nucleotidase in the interaction between L. amazonensis and macrophages using CrATP.

Main Methods:

  • Enzyme kinetics to determine inhibition constants (Ki) and Michaelis constants (Km) for CrATP.
  • Cell culture to assess the effect of CrATP on L. amazonensis growth.
  • Macrophage-parasite interaction assays to measure adhesion and endocytosis.

Main Results:

  • CrATP partially inhibited ecto-ATPase activity with non-competitive reversible kinetics.
  • CrATP at 500 μm drastically inhibited L. amazonensis promastigote growth.
  • Pre-treatment of L. amazonensis with CrATP significantly reduced parasite adhesion (53.0±14.8%) and endocytosis (39.8±1.1%) by macrophages.

Conclusions:

  • Ecto-nucleotidase activity is essential for the infectivity of Leishmania amazonensis.
  • CrATP is a potent inhibitor of L. amazonensis growth and macrophage interaction, suggesting its potential as an anti-leishmanial agent.

Related Concept Videos

Leishmaniasis01:30

Leishmaniasis

Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...
Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...
Malaria01:29

Malaria

Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...
American Trypanosomiasis01:22

American Trypanosomiasis

Chagas disease, or American trypanosomiasis, is a vector-borne parasitic infection caused by Trypanosoma cruzi, a flagellated protozoan (kinetoplastid) of the family Trypanosomatidae. The disease is endemic in Latin America, although cases are increasingly reported worldwide due to human migration. Transmission most commonly occurs when feces of infected triatomine bugs contaminate bite wounds or mucosal surfaces; additional routes include congenital, transfusional, transplant-related, and oral...